Application 210534
- Type
- ANDA
- Sponsor
- ALKEM LABS LTD
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | CEFDINIR | CEFDINIR | FOR SUSPENSION;ORAL | 125MG/5ML | No | No |
| 002 | CEFDINIR | CEFDINIR | FOR SUSPENSION;ORAL | 250MG/5ML | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A210534-001 | CEFDINIR | CEFDINIR | 125MG/5ML | FOR SUSPENSION / ORAL | AB | 2021-02-19 | |
| A210534-002 | CEFDINIR | CEFDINIR | 250MG/5ML | FOR SUSPENSION / ORAL | AB | 2021-02-19 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A210534-001 | AB |
| A210534-002 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A210534-001 | CEFDINIR | 125MG/5ML | FOR SUSPENSION / ORAL | AB | 2021-02-19 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A210534-002 | CEFDINIR | 250MG/5ML | FOR SUSPENSION / ORAL | AB | 2021-02-19 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A210534-001 | CEFDINIR | 125MG/5ML | FOR SUSPENSION / ORAL | AB | 2021-02-19 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A210534-002 | CEFDINIR | 250MG/5ML | FOR SUSPENSION / ORAL | AB | 2021-02-19 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A210534-001 | CEFDINIR | 125MG/5ML | FOR SUSPENSION / ORAL | AB | 2021-02-19 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A210534-002 | CEFDINIR | 250MG/5ML | FOR SUSPENSION / ORAL | AB | 2021-02-19 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A210534-001 | CEFDINIR | 125MG/5ML | FOR SUSPENSION / ORAL | AB | 2021-02-19 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A210534-002 | CEFDINIR | 250MG/5ML | FOR SUSPENSION / ORAL | AB | 2021-02-19 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A210534-001 | CEFDINIR | 125MG/5ML | FOR SUSPENSION / ORAL | AB | 2021-02-19 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A210534-002 | CEFDINIR | 250MG/5ML | FOR SUSPENSION / ORAL | AB | 2021-02-19 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A210534-001 | CEFDINIR | 125MG/5ML | FOR SUSPENSION / ORAL | AB | 2021-02-19 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A210534-002 | CEFDINIR | 250MG/5ML | FOR SUSPENSION / ORAL | AB | 2021-02-19 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A210534-001 | CEFDINIR | 125MG/5ML | FOR SUSPENSION / ORAL | AB | 2021-02-19 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A210534-002 | CEFDINIR | 250MG/5ML | FOR SUSPENSION / ORAL | AB | 2021-02-19 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A210534-001 | CEFDINIR | 125MG/5ML | FOR SUSPENSION / ORAL | AB | 2021-02-19 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A210534-002 | CEFDINIR | 250MG/5ML | FOR SUSPENSION / ORAL | AB | 2021-02-19 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A210534-001 | CEFDINIR | 125MG/5ML | FOR SUSPENSION / ORAL | AB | 2021-02-19 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A210534-002 | CEFDINIR | 250MG/5ML | FOR SUSPENSION / ORAL | AB | 2021-02-19 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | A210534-001 | CEFDINIR | 125MG/5ML | FOR SUSPENSION / ORAL | AB | 2021-02-19 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | A210534-002 | CEFDINIR | 250MG/5ML | FOR SUSPENSION / ORAL | AB | 2021-02-19 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A210534-001 | CEFDINIR | 125MG/5ML | FOR SUSPENSION / ORAL | AB | 2021-02-19 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A210534-002 | CEFDINIR | 250MG/5ML | FOR SUSPENSION / ORAL | AB | 2021-02-19 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A210534-001 | CEFDINIR | 125MG/5ML | FOR SUSPENSION / ORAL | AB | 2021-02-19 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A210534-002 | CEFDINIR | 250MG/5ML | FOR SUSPENSION / ORAL | AB | 2021-02-19 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A210534-001 | CEFDINIR | 125MG/5ML | FOR SUSPENSION / ORAL | AB | 2021-02-19 | 1e350fbaab3a… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A210534-002 | CEFDINIR | 250MG/5ML | FOR SUSPENSION / ORAL | AB | 2021-02-19 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | A210534-001 | CEFDINIR | 125MG/5ML | FOR SUSPENSION / ORAL | AB | 2021-02-19 | 8072bd15b7f6… | |
| 2024-05-31 18:47 UTC | 2024-05 | A210534-002 | CEFDINIR | 250MG/5ML | FOR SUSPENSION / ORAL | AB | 2021-02-19 | 8072bd15b7f6… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A210534-001 | CEFDINIR | 125MG/5ML | FOR SUSPENSION / ORAL | AB | 2021-02-19 | 5c6f7cd8ea54… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A210534-002 | CEFDINIR | 250MG/5ML | FOR SUSPENSION / ORAL | AB | 2021-02-19 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | A210534-001 | CEFDINIR | 125MG/5ML | FOR SUSPENSION / ORAL | AB | 2021-02-19 | 5d02ea3f76ae… | |
| 2022-04-08 23:34 UTC | 2022-04 | A210534-002 | CEFDINIR | 250MG/5ML | FOR SUSPENSION / ORAL | AB | 2021-02-19 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | A210534-001 | CEFDINIR | 125MG/5ML | FOR SUSPENSION / ORAL | AB | 2021-02-19 | 4b0b4de00fa7… | |
| 2022-04-04 05:41 UTC | 2022-04 | A210534-002 | CEFDINIR | 250MG/5ML | FOR SUSPENSION / ORAL | AB | 2021-02-19 | 4b0b4de00fa7… | |
| 2022-03-09 01:35 UTC | 2022-03 | A210534-001 | CEFDINIR | 125MG/5ML | FOR SUSPENSION / ORAL | AB | 2021-02-19 | bb7c543d1eb4… | |
| 2022-03-09 01:35 UTC | 2022-03 | A210534-002 | CEFDINIR | 250MG/5ML | FOR SUSPENSION / ORAL | AB | 2021-02-19 | bb7c543d1eb4… | |
| 2021-12-28 21:50 UTC | 2021-12 | A210534-001 | CEFDINIR | 125MG/5ML | FOR SUSPENSION / ORAL | AB | 2021-02-19 | 782e0a99824c… | |
| 2021-12-28 21:50 UTC | 2021-12 | A210534-002 | CEFDINIR | 250MG/5ML | FOR SUSPENSION / ORAL | AB | 2021-02-19 | 782e0a99824c… | |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A210534-001 | CEFDINIR | 125MG/5ML | FOR SUSPENSION / ORAL | AB | 2021-02-19 | 87673890dc5c… | |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A210534-002 | CEFDINIR | 250MG/5ML | FOR SUSPENSION / ORAL | AB | 2021-02-19 | 87673890dc5c… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A210534-001 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A210534-002 | AB | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A210534-001 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A210534-002 | AB | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A210534-001 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A210534-002 | AB | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A210534-001 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A210534-002 | AB | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A210534-001 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A210534-002 | AB | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A210534-001 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A210534-002 | AB | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A210534-001 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A210534-002 | AB | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A210534-001 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A210534-002 | AB | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A210534-001 | AB | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A210534-002 | AB | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A210534-001 | AB | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A210534-002 | AB | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A210534-001 | AB | 1 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A210534-002 | AB | 1 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A210534-001 | AB | 1 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A210534-002 | AB | 1 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A210534-001 | AB | 1 | 1e350fbaab3a… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A210534-002 | AB | 1 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | A210534-001 | AB | 1 | 8072bd15b7f6… |
| 2024-05-31 18:47 UTC | 2024-05 | A210534-002 | AB | 1 | 8072bd15b7f6… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A210534-001 | AB | 1 | 5c6f7cd8ea54… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A210534-002 | AB | 1 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | A210534-001 | AB | 1 | 5d02ea3f76ae… |
| 2022-04-08 23:34 UTC | 2022-04 | A210534-002 | AB | 1 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | A210534-001 | AB | 1 | 4b0b4de00fa7… |
| 2022-04-04 05:41 UTC | 2022-04 | A210534-002 | AB | 1 | 4b0b4de00fa7… |
| 2022-03-09 01:35 UTC | 2022-03 | A210534-001 | AB | 1 | bb7c543d1eb4… |
| 2022-03-09 01:35 UTC | 2022-03 | A210534-002 | AB | 1 | bb7c543d1eb4… |
| 2021-12-28 21:50 UTC | 2021-12 | A210534-001 | AB | 1 | 782e0a99824c… |
| 2021-12-28 21:50 UTC | 2021-12 | A210534-002 | AB | 1 | 782e0a99824c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A210534-001 | AB | 1 | 87673890dc5c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A210534-002 | AB | 1 | 87673890dc5c… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| cefdinir | CEFDINIR | Preferred Pharmaceuticals Inc. | 2e384d98-642e-4841-9f62-fcea4c242f4e | 2026-03-24 | Warnings, Adverse reactions | 210534 ANDA210534 68788-8115 |
| cefdinir | CEFDINIR | A-S Medication Solutions | 2bd2101c-511d-45a9-b1d8-a45ed40c5b80 | 2026-03-12 | Warnings, Adverse reactions | 210534 ANDA210534 |
| CEFDINIR | CEFDINIR | DIRECT RX | 982d0f53-20bc-1cb4-e053-2995a90ad33c | 2025-01-22 | Warnings | 210534 ANDA210534 72189-259 |
| cefdinir | CEFDINIR | A-S Medication Solutions | 7bbcc4ac-c964-4c6b-88c0-11c0ba9933db | 2023-11-24 | Warnings, Adverse reactions | 210534 ANDA210534 50090-5811 |
| cefdinir | CEFDINIR | Ascend Laboratories, LLC | efb5a975-75ec-46e1-ba84-f68d0b9bf36f | 2022-06-29 | Warnings, Adverse reactions | 210534 ANDA210534 67877-548 67877-547 |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 50090-5811 | cefdinir | cefdinir | A-S Medication Solutions | ANDA | Current |
| 67877-547 | cefdinir | cefdinir | Ascend Laboratories, LLC | ANDA | Current |
| 67877-547 | cefdinir | cefdinir | Ascend Laboratories, LLC | ANDA | Current |
| 67877-547 | cefdinir | cefdinir | Ascend Laboratories, LLC | ANDA | Current |
| 67877-548 | cefdinir | cefdinir | Ascend Laboratories, LLC | ANDA | Current |
| 67877-548 | cefdinir | cefdinir | Ascend Laboratories, LLC | ANDA | Current |
| 67877-548 | cefdinir | cefdinir | Ascend Laboratories, LLC | ANDA | Current |
| 68071-2493 | cefdinir | cefdinir | NuCare Pharmaceuticals,Inc. | ANDA | Current |
| 68071-2493 | cefdinir | cefdinir | NuCare Pharmaceuticals,Inc. | ANDA | Current |
| 68071-2564 | cefdinir | cefdinir | NuCare Pharmaceuticals,Inc. | ANDA | Current |
| 68071-2683 | Cefdinir | Cefdinir | NuCare Pharmaceuticals,Inc. | ANDA | Current |
| 68788-8062 | cefdinir | cefdinir | Preferred Pharmaceuticals Inc. | ANDA | Current |
| 68788-8062 | cefdinir | cefdinir | Preferred Pharmaceuticals Inc. | ANDA | Current |
| 68788-8115 | cefdinir | cefdinir | Preferred Pharmaceuticals Inc. | ANDA | Current |
| 68788-8115 | cefdinir | cefdinir | Preferred Pharmaceuticals Inc. | ANDA | Current |
| 72189-259 | CEFDINIR | CEFDINIR | DIRECT RX | ANDA | Current |
| 72189-259 | CEFDINIR | CEFDINIR | DIRECT RX | ANDA | Current |